Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

RNY (Roux-en-Y) gastric bypass and the gastric sleeve (sleeve gastrectomy) are two of the most common bariatric surgeries. While both procedures restrict the stomach’s size, the RNY bypass also reroutes part of the small intestine, reducing calorie absorption. The sleeve removes a large portion of the stomach without altering the intestines. The choice between the two depends on the patient’s health, goals, and surgeon recommendations.

After Vertical Sleeve Gastrectomy (VSG), patients must follow a strict diet to ensure the stomach heals properly and to promote weight loss. The post-op diet begins with liquids and progresses to soft foods, and eventually solids. It emphasizes protein intake, hydration, and portion control to avoid complications like vomiting or nutrient deficiencies.

A pre-surgery diet prepares the body for bariatric surgery, typically focusing on reducing liver size and overall fat to make the procedure safer. This high-protein, low-carbohydrate diet often lasts for 1-2 weeks before surgery. Patients must follow a strict plan of liquids and protein shakes to shrink the liver and facilitate surgery.

Gastritis is inflammation of the stomach lining, while Irritable Bowel Syndrome (IBS) affects the intestines and causes chronic discomfort without inflammation. While both conditions involve digestive issues, gastritis typically causes nausea and upper abdominal pain, whereas IBS presents with bloating, diarrhea, or constipation.